680C91 (Standard)
680C91 (Standard) is the analytical standard of 680C91 (HY-108681). This product is intended for research and analytical applications. 680C91 is an orally active, selective tryptophan 2,3-dioxygenase (TDO) inhibitor with a Ki of 51 nM. TDO is the key enzyme of tryptophan catabolism. 680C91 can be used for the research of cancer immunotherapy and Alzheimer’s Disease.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 163239-22-3
- Formule: C15H11FN2
- Masse moléculaire:238.26
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureté et documentation
-
Help & FAQs
-
HY-108681
680C91TDO Inhibitor -
HY-33298
LM10TDO Inhibitor -
HY-130055
HQNONDH-2 Inhibitor -
HY-100621
MDL 72527Polyamine Oxidase Inhibitor -
HY-18770B
NavoximodIDO Inhibitor -
HY-15683
IDO5LIDO Inhibitor -
HY-130055R
HQNO (Standard)NDH-2 Inhibitor -
HY-100621R
MDL 72527 (Standard)Polyamine Oxidase Inhibitor -
HY-15683R
IDO5L (Standard)IDO Inhibitor -
HY-108680
Carbazeran citratePhosphodiesterase Inhibitor
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 163239-22-3
-
Masse moléculaire 238.26
-
Formule C15H11FN2
-
SMILES
FC1=CC2=C(C=C1)C(/C=C/C3=CC=CN=C3)=CN2
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Li DD, et al. Differential expression and regulation of Tdo2 during mouse decidualization. J Endocrinol. 2013 Dec 2;220(1):73-83. [Content Brief]
[2]. M Salter, et al. The effects of an inhibitor of tryptophan 2,3-dioxygenase and a combined inhibitor of tryptophan 2,3-dioxygenase and 5-HT reuptake in the rat. Neuropharmacology. 1995 Feb;34(2):217-27. [Content Brief]
[3]. M Salter, et al. The effects of a novel and selective inhibitor of tryptophan 2,3-dioxygenase on tryptophan and serotonin metabolism in the rat. Biochem Pharmacol. 1995 May 17;49(10):1435-42. [Content Brief]
[5]. Tsai-Der Chuang, et al. Tryptophan catabolism is dysregulated in leiomyomas. Fertil Steril. 2021 Oct;116(4):1160-1171. [Content Brief]
[6]. Sophie Imbeault, et al. Effects of IDO1 and TDO2 inhibition on cognitive deficits and anxiety following LPS-induced neuroinflammation. Acta Neuropsychiatr. 2020 Feb;32(1):43-53. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
680C91 (Standard) Related Classifications
HY-108681R Related Classifications
Powered by Bioz